Literature DB >> 12933481

Bowel wall fat halo sign in patients without intestinal disease.

Mukesh G Harisinghani1, Jack Wittenberg, Winnie Lee, Steven Chen, Ana Luiza Gutierrez, Peter R Mueller.   

Abstract

OBJECTIVE: Stratification with a fat layer in the intestinal wall is thought to be a reliable marker for inflammatory bowel disease. We evaluated the presence and frequency of the bowel wall fat halo sign in patients undergoing abdominal CT for clinical indications unrelated to the gastrointestinal tract.
MATERIALS AND METHODS: We performed a retrospective review of 100 consecutive abdominal and pelvic CT examinations in 61 men and 39 women (mean age, 56 years) with clinical suspicion of renal stone disease. Two radiologists experienced in abdominal imaging performed qualitative and quantifiable assessment of the images. Five segments of the colon (ascending colon, transverse colon, descending colon, sigmoid colon, and rectum) and the terminal ileum (for approximately 1 ft [30 cm]) were evaluated for the presence of the fat halo sign. If the fat halo sign was present, fat density and total wall-thickness assessments were made. Presence or absence of clinical and radiologic signs of inflammatory bowel disease was determined. The Student's t test was used to evaluate the statistical significance, correlating body weight and presence of the halo sign.
RESULTS: The fat halo sign was seen in 21 (21%) of 100 patients. Of the 21 patients with the fat halo sign, six (29%) had renal stone disease and 15 (71%) had no stone disease. The density value of the halo sign ranged from -18 to -64 H (mean, -41 H). The distribution of the fat halo sign was as follows: the terminal ileum, 4%; the ascending colon, 28%; the transverse colon, 34%; the descending colon, 36%; the sigmoid colon, 14%; and rectum, 10%. No patient with this sign had any remote, recent, or subsequently recorded history of inflammatory bowel disease. A statistically significant relationship (p < 0.001) was seen between the presence of the fat halo sign and body weight distribution, with 16 of 21 patients weighing over 200 lb (90 kg).
CONCLUSION: In the absence of clinical or radiologic evidence of inflammatory bowel disease, the presence of the fat halo sign may represent a normal finding that is possibly related to obesity.

Entities:  

Mesh:

Year:  2003        PMID: 12933481     DOI: 10.2214/ajr.181.3.1810781

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Submerging endoscopic submucosal dissection leads to successful en bloc resection of colonic laterally spreading tumor with submucosal fat.

Authors:  Satoshi Ono; Mitsuhiro Fujishiro; Osamu Goto; Shinya Kodashima; Masao Omata
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

2.  Gastric Lipohyperplasia Presenting as Gastric Polyposis: the First Case Report and Morphometric Study of Additional 127 Bariatric Specimens with a Proposal for Diagnostic Criteria.

Authors:  Vaibhav Chumbalkar; Zhiyan Fu; Ann Boguniewicz; Tejinder P Singh; Hwajeong Lee
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

3.  Fat-only Dixon: how to use it in body MRI.

Authors:  Reza Salari; David H Ballard; Mark J Hoegger; Daniel Young; Anup S Shetty
Journal:  Abdom Radiol (NY)       Date:  2022-05-18

4.  Features and perspectives of MR enterography for pediatric Crohn disease assessment.

Authors:  Noemi Maria Giovanna Ognibene; Massimo Basile; Marco Di Maurizio; Giuseppe Petrillo; Claudio De Filippi
Journal:  Radiol Med       Date:  2016-02-02       Impact factor: 3.469

5.  Role of tissue microenvironment resident adipocytes in colon cancer.

Authors:  Maria Tabuso; Shervanthi Homer-Vanniasinkam; Raghu Adya; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

6.  Interpretable survival prediction for colorectal cancer using deep learning.

Authors:  Kurt Zatloukal; Craig H Mermel; Ellery Wulczyn; David F Steiner; Melissa Moran; Markus Plass; Robert Reihs; Fraser Tan; Isabelle Flament-Auvigne; Trissia Brown; Peter Regitnig; Po-Hsuan Cameron Chen; Narayan Hegde; Apaar Sadhwani; Robert MacDonald; Benny Ayalew; Greg S Corrado; Lily H Peng; Daniel Tse; Heimo Müller; Zhaoyang Xu; Yun Liu; Martin C Stumpe
Journal:  NPJ Digit Med       Date:  2021-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.